Annual Net Income
-$80.74 M
-$9.70 M-13.65%
December 31, 2023
Summary
- As of February 7, 2025, OCUL annual net profit is -$80.74 million, with the most recent change of -$9.70 million (-13.65%) on December 31, 2023.
- During the last 3 years, OCUL annual net income has risen by +$74.90 million (+48.13%).
- OCUL annual net income is now -1132.05% below its all-time high of -$6.55 million, reached on December 31, 2021.
Performance
OCUL Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$36.49 M
+$7.28 M+16.64%
September 30, 2024
Summary
- As of February 7, 2025, OCUL quarterly net profit is -$36.49 million, with the most recent change of +$7.28 million (+16.64%) on September 30, 2024.
- Over the past year, OCUL quarterly net income has dropped by -$35.98 million (-6972.29%).
- OCUL quarterly net income is now -1269.27% below its all-time high of $3.12 million, reached on March 31, 2021.
Performance
OCUL Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$174.34 M
-$35.98 M-26.00%
September 30, 2024
Summary
- As of February 7, 2025, OCUL TTM net profit is -$174.34 million, with the most recent change of -$35.98 million (-26.00%) on September 30, 2024.
- Over the past year, OCUL TTM net income has dropped by -$107.28 million (-159.98%).
- OCUL TTM net income is now -5348.06% below its all-time high of -$3.20 million, reached on March 31, 2013.
Performance
OCUL TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
OCUL Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.7% | -6972.3% | -160.0% |
| 3 y3 years | +48.1% | -1473.5% | -97.4% |
| 5 y5 years | -34.6% | -94.3% | -101.8% |
OCUL Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1132.0% | at low | -6972.3% | +43.7% | -2560.4% | at low |
| 5 y | 5-year | -1132.0% | +48.1% | -1269.3% | +57.4% | -2560.4% | at low |
| alltime | all time | -1132.0% | +48.1% | -1269.3% | +57.4% | -5348.1% | at low |
Ocular Therapeutix Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$36.49 M(-16.6%) | -$174.34 M(+26.0%) |
| Jun 2024 | - | -$43.78 M(-32.5%) | -$138.36 M(+20.0%) |
| Mar 2024 | - | -$64.85 M(+121.9%) | -$115.27 M(+42.8%) |
| Dec 2023 | -$80.74 M(+13.7%) | -$29.22 M(+5562.8%) | -$80.74 M(+20.4%) |
| Sep 2023 | - | -$516.00 K(-97.5%) | -$67.06 M(-26.1%) |
| Jun 2023 | - | -$20.68 M(-31.8%) | -$90.73 M(+2.2%) |
| Mar 2023 | - | -$30.32 M(+95.1%) | -$88.81 M(+25.0%) |
| Dec 2022 | -$71.04 M(+984.1%) | -$15.54 M(-35.7%) | -$71.04 M(+19.7%) |
| Sep 2022 | - | -$24.19 M(+28.9%) | -$59.35 M(+82.6%) |
| Jun 2022 | - | -$18.77 M(+49.6%) | -$32.50 M(+46.3%) |
| Mar 2022 | - | -$12.54 M(+225.8%) | -$22.22 M(+239.0%) |
| Dec 2021 | -$6.55 M(-95.8%) | -$3.85 M(-244.9%) | -$6.55 M(-92.6%) |
| Sep 2021 | - | $2.66 M(-131.3%) | -$88.31 M(-14.2%) |
| Jun 2021 | - | -$8.48 M(-371.7%) | -$102.92 M(-21.4%) |
| Mar 2021 | - | $3.12 M(-103.6%) | -$131.00 M(-15.8%) |
| Dec 2020 | -$155.64 M(+80.2%) | -$85.61 M(+616.8%) | -$155.64 M(+62.1%) |
| Sep 2020 | - | -$11.94 M(-67.3%) | -$96.04 M(-6.6%) |
| Jun 2020 | - | -$36.57 M(+70.0%) | -$102.88 M(+13.3%) |
| Mar 2020 | - | -$21.51 M(-17.3%) | -$90.76 M(+5.1%) |
| Dec 2019 | -$86.37 M(+44.0%) | -$26.02 M(+38.6%) | -$86.37 M(+11.1%) |
| Sep 2019 | - | -$18.78 M(-23.2%) | -$77.75 M(+5.1%) |
| Jun 2019 | - | -$24.45 M(+42.8%) | -$73.99 M(+16.8%) |
| Mar 2019 | - | -$17.12 M(-1.6%) | -$63.34 M(+5.6%) |
| Dec 2018 | -$59.98 M | -$17.40 M(+15.9%) | -$59.98 M(+7.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$15.01 M(+8.7%) | -$55.68 M(-1.0%) |
| Jun 2018 | - | -$13.80 M(+0.3%) | -$56.24 M(-8.0%) |
| Mar 2018 | - | -$13.77 M(+5.1%) | -$61.13 M(-3.6%) |
| Dec 2017 | -$63.39 M(+41.8%) | -$13.10 M(-15.8%) | -$63.39 M(+0.4%) |
| Sep 2017 | - | -$15.57 M(-16.7%) | -$63.11 M(+10.5%) |
| Jun 2017 | - | -$18.69 M(+16.7%) | -$57.13 M(+14.5%) |
| Mar 2017 | - | -$16.02 M(+25.0%) | -$49.89 M(+11.6%) |
| Dec 2016 | -$44.70 M(+12.5%) | -$12.82 M(+33.6%) | -$44.70 M(+5.1%) |
| Sep 2016 | - | -$9.60 M(-16.2%) | -$42.52 M(-4.3%) |
| Jun 2016 | - | -$11.45 M(+5.6%) | -$44.45 M(+3.3%) |
| Mar 2016 | - | -$10.84 M(+1.9%) | -$43.01 M(+8.2%) |
| Dec 2015 | -$39.75 M(+38.7%) | -$10.64 M(-7.7%) | -$39.75 M(+7.2%) |
| Sep 2015 | - | -$11.52 M(+15.1%) | -$37.06 M(+12.9%) |
| Jun 2015 | - | -$10.01 M(+32.1%) | -$32.84 M(+12.4%) |
| Mar 2015 | - | -$7.58 M(-4.7%) | -$29.22 M(+2.0%) |
| Dec 2014 | -$28.65 M(+115.1%) | -$7.95 M(+9.0%) | -$28.65 M(+18.4%) |
| Sep 2014 | - | -$7.29 M(+14.1%) | -$24.20 M(+18.5%) |
| Jun 2014 | - | -$6.39 M(-8.8%) | -$20.43 M(+19.3%) |
| Mar 2014 | - | -$7.01 M(+99.9%) | -$17.13 M(+28.6%) |
| Dec 2013 | -$13.32 M(-5.5%) | -$3.50 M(-0.5%) | -$13.32 M(+35.7%) |
| Sep 2013 | - | -$3.52 M(+14.0%) | -$9.81 M(+56.0%) |
| Jun 2013 | - | -$3.09 M(-3.4%) | -$6.29 M(+96.6%) |
| Mar 2013 | - | -$3.20 M | -$3.20 M |
| Dec 2012 | -$14.09 M | - | - |
FAQ
- What is Ocular Therapeutix annual net profit?
- What is the all time high annual net income for Ocular Therapeutix?
- What is Ocular Therapeutix annual net income year-on-year change?
- What is Ocular Therapeutix quarterly net profit?
- What is the all time high quarterly net income for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly net income year-on-year change?
- What is Ocular Therapeutix TTM net profit?
- What is the all time high TTM net income for Ocular Therapeutix?
- What is Ocular Therapeutix TTM net income year-on-year change?
What is Ocular Therapeutix annual net profit?
The current annual net income of OCUL is -$80.74 M
What is the all time high annual net income for Ocular Therapeutix?
Ocular Therapeutix all-time high annual net profit is -$6.55 M
What is Ocular Therapeutix annual net income year-on-year change?
Over the past year, OCUL annual net profit has changed by -$9.70 M (-13.65%)
What is Ocular Therapeutix quarterly net profit?
The current quarterly net income of OCUL is -$36.49 M
What is the all time high quarterly net income for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly net profit is $3.12 M
What is Ocular Therapeutix quarterly net income year-on-year change?
Over the past year, OCUL quarterly net profit has changed by -$35.98 M (-6972.29%)
What is Ocular Therapeutix TTM net profit?
The current TTM net income of OCUL is -$174.34 M
What is the all time high TTM net income for Ocular Therapeutix?
Ocular Therapeutix all-time high TTM net profit is -$3.20 M
What is Ocular Therapeutix TTM net income year-on-year change?
Over the past year, OCUL TTM net profit has changed by -$107.28 M (-159.98%)